Thus, an ACE2-mediated invasion of pancreatic islet cells and/or dysregulation of SGLT1 in intestinal epithelium may be plausible mechanisms for the new onset of diabetes in COVID-19 patients. This evidence concerns the gene SLC5A1 and diabetes mellitus.